Yousef Assad, NancyAhmed Ehsan, NermineGaber Abdou, AsmaaAhmed El-Tahmody, MohamedMohamed El-Sabaawy, MahaFarag El-Naidany, NadaSaad El-Kholy, Shimaa2020-03-172020-03-1720141110-2098https://doi.org/10.4103/1110-2098.149768https://cutt.ly/utjSj7PMSA Google ScholarThis study aimed to investigate the impact of clinical and histopathological changes in liver tissue of responders and nonresponders to standard pegylated interferon (Peg-IFN) and ribavirin (RBV) therapy and to determine whether they could predict treatment outcome or noenChronic hepatitis Chistopathological changes impactinterferonresponse to therapyThe impact of clinicopathological parameters in predicting response to pegylated interferon and ribavirin in chronic hepatitis C patientsArticlehttps://doi.org/10.4103/1110-2098.149768